Template:Osteomyelitis Antibiotics: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
(Convert to {{AntibioticDose}} for SMW antibiotic-disease linking with Adult/Pediatric population tracking) |
||
| Line 7: | Line 7: | ||
| Elderly, hematogenous spread | | Elderly, hematogenous spread | ||
| [[MRSA]], [[MSSA]], [[gram neg]] | | [[MRSA]], [[MSSA]], [[gram neg]] | ||
| | | {{AntibioticDose|drug=Vancomycin|dose=1gm|context=Elderly/Hematogenous}} + ({{AntibioticDose|drug=Piperacillin/Tazobactam|dose=3.375 grams|context=Elderly/Hematogenous}} OR {{AntibioticDose|drug=Imipenem|dose=500mg|context=Elderly/Hematogenous}}) | ||
|- | |- | ||
| [[Sickle Cell Disease]] | | [[Sickle Cell Disease]] | ||
| [[Salmonella]], [[gram-negative]] bacteria | | [[Salmonella]], [[gram-negative]] bacteria | ||
| | | {{AntibioticDose|drug=Ceftriaxone|dose=50mg/kg IV once daily|context=Sickle Cell Disease|population=Pediatric}} OR {{AntibioticDose|drug=Cefotaxime|dose=50mg/kg IV three times daily|context=Sickle Cell Disease|population=Pediatric}}, PLUS<br> | ||
* | *{{AntibioticDose|drug=Vancomycin|dose=15mg/kg IV four times daily|context=Sickle Cell Disease|population=Pediatric}} OR | ||
* | *{{AntibioticDose|drug=Clindamycin|dose=10mg/kg IV PO four times daily|context=Sickle Cell Disease|population=Pediatric}} OR | ||
* | *{{AntibioticDose|drug=Nafcillin|dose=50 mg/kg IV four times daily|context=Sickle Cell Disease|population=Pediatric}} to cover K. Kingae (common in daycare population) | ||
|- | |- | ||
| [[DM]] or vascular insufficiency | | [[DM]] or vascular insufficiency | ||
| Polymicrobial: [[Staph]], [[strep]], coliforms, [[anaerobes]] | | Polymicrobial: [[Staph]], [[strep]], coliforms, [[anaerobes]] | ||
| | | {{AntibioticDose|drug=Vancomycin|dose=1gm|context=DM/Vascular insufficiency}} + ({{AntibioticDose|drug=Piperacillin/Tazobactam|dose=3.375 grams|context=DM/Vascular insufficiency}} OR {{AntibioticDose|drug=Imipenem|dose=500mg|context=DM/Vascular insufficiency}}) | ||
|- | |- | ||
| [[IVDU|IV drug]] user | | [[IVDU|IV drug]] user | ||
| [[MRSA]], [[MSSA]], [[pseudomonas]] | | [[MRSA]], [[MSSA]], [[pseudomonas]] | ||
| | | {{AntibioticDose|drug=Vancomycin|dose=1gm|context=IVDU}} | ||
|- | |- | ||
| Newborn | | Newborn | ||
| [[MRSA]], [[MSSA]], [[group B strep|GBS]], [[Gram Negative]] | | [[MRSA]], [[MSSA]], [[group B strep|GBS]], [[Gram Negative]] | ||
| | | {{AntibioticDose|drug=Vancomycin|dose=15mg/kg load, then reduce dose|context=Newborn|population=Pediatric}}, AND {{AntibioticDose|drug=Ceftazidime|dose=30mg/kg IV q12 h|context=Newborn|population=Pediatric}} | ||
|- | |- | ||
| Children | | Children | ||
| [[MRSA]], [[MSSA]] | | [[MRSA]], [[MSSA]] | ||
| | | {{AntibioticDose|drug=Vancomycin|dose=10mg/kg q6 h|context=Children|population=Pediatric}} AND {{AntibioticDose|drug=Ceftazidime|dose=50mg/kg q8hr|context=Children|population=Pediatric}} | ||
|- | |- | ||
| Postoperative (ortho) | | Postoperative (ortho) | ||
| [[MRSA]], [[MSSA]] | | [[MRSA]], [[MSSA]] | ||
| | | {{AntibioticDose|drug=Vancomycin|dose=1gm|context=Postoperative}} | ||
|- | |- | ||
| [[Human bite]] | | [[Human bite]] | ||
| [[Strep]], [[anaerobes]], HACEK organism | | [[Strep]], [[anaerobes]], HACEK organism | ||
| | | {{AntibioticDose|drug=Piperacillin/Tazobactam|dose=3.375gm|context=Human bite}} OR {{AntibioticDose|drug=Imipenem|dose=500mg|context=Human bite}} | ||
|- | |- | ||
| [[Animal bites]] | | [[Animal bites]] | ||
| [[Pasteurella]], [[Eikenella]], HACEK organism | | [[Pasteurella]], [[Eikenella]], HACEK organism | ||
| | | {{AntibioticDose|drug=Piperacillin/Tazobactam|dose=3.375gm|context=Animal bites}} OR {{AntibioticDose|drug=Imipenem|dose=500mg|context=Animal bites}} | ||
|- | |- | ||
| Foot puncture wound | | Foot puncture wound | ||
| [[Pseudomonas]] | | [[Pseudomonas]] | ||
| Anti-pseudomonal, staph coverage | | Anti-pseudomonal, staph coverage | ||
|} | |} | ||
Revision as of 20:40, 19 March 2026
| Risk Factor | Likely Organism | Initial Empiric Antibiotic Therapy' |
| Elderly, hematogenous spread | MRSA, MSSA, gram neg | Vancomycin 1gm + (Piperacillin/Tazobactam 3.375 grams OR Imipenem 500mg) |
| Sickle Cell Disease | Salmonella, gram-negative bacteria | Ceftriaxone 50mg/kg IV once daily OR Cefotaxime 50mg/kg IV three times daily, PLUS
|
| DM or vascular insufficiency | Polymicrobial: Staph, strep, coliforms, anaerobes | Vancomycin 1gm + (Piperacillin/Tazobactam 3.375 grams OR Imipenem 500mg) |
| IV drug user | MRSA, MSSA, pseudomonas | Vancomycin 1gm |
| Newborn | MRSA, MSSA, GBS, Gram Negative | Vancomycin 15mg/kg load, then reduce dose, AND Ceftazidime 30mg/kg IV q12 h |
| Children | MRSA, MSSA | Vancomycin 10mg/kg q6 h AND Ceftazidime 50mg/kg q8hr |
| Postoperative (ortho) | MRSA, MSSA | Vancomycin 1gm |
| Human bite | Strep, anaerobes, HACEK organism | Piperacillin/Tazobactam 3.375gm OR Imipenem 500mg |
| Animal bites | Pasteurella, Eikenella, HACEK organism | Piperacillin/Tazobactam 3.375gm OR Imipenem 500mg |
| Foot puncture wound | Pseudomonas | Anti-pseudomonal, staph coverage |